Carcinogenesis and Diet Restriction
暂无分享,去创建一个
[1] T. Bauknecht,et al. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. , 1989, Anticancer research.
[2] J. Shepherd. Revised FIGO staging for gynaecological cancer , 1989, British journal of obstetrics and gynaecology.
[3] C. Osborne,et al. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis. , 1988, Cancer research.
[4] J. Young,et al. The contribution of the C-terminal undecapeptide sequence of urogastrone-epidermal growth factor to its biological action , 1988, Regulatory Peptides.
[5] D. V. Von Hoff,et al. Determination of transforming growth factor activity in effusions from cancer patients , 1988, Cancer.
[6] G. Bauer,et al. Characterization of growth factors in human ovarian carcinomas. , 1986, Cancer research.
[7] Anita B. Roberts,et al. Autocrine growth factors and cancer , 1985, Nature.
[8] E. S. Kimball,et al. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals. , 1984, Cancer research.
[9] S. Cowan,et al. New storage procedure for human tumor biopsies prior to estrogen receptor measurement. , 1984, Cancer research.
[10] D. Twardzik,et al. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer. , 1983, Cancer research.
[11] H. Antoniades,et al. Human platelet-derived growth factor stimulates amino acid transport and protein synthesis by human diploid fibroblasts in plasma-free media. , 1982, Proceedings of the National Academy of Sciences of the United States of America.